Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,588.81
(
0.33%
)
US TECH 100
29,549.60
(
0.43%
)
Dow Jones
51,059.79
(
0.77%
)
Brent Oil
90.78
(
-1.52%
)
Bitcoin
73,655.87
(
0.16%
)
News Focus
News Focus
Post# of 257654
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123033
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: alertmeipp post# 81561

Tuesday, 07/28/2009 4:24:27 PM

Tuesday, July 28, 2009 4:24:27 PM

Post# of 257654
TEVA BIIB ELN:

But if u look at just the last couple quarters... Tysabri is superior :)

Actually, it wasn’t. Referring to the table in #msg-39941769: in the past two quarters, the cumulative growth of US Tysabri sales was 8.7% while the cumulative growth of US Copaxone sales was 14.1%.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today